Clinical Trial Update: Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating the optimal administration scheme of pazopanib in thyroid carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Carcinoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: Centre Leon Berard | Conditions: Thyroid Carcinoma | Phase 2 | Status: COMPLETED